Functional analyses reveal that depletion of LAPTM4B sensitizes NSCLC cells to EGFR-TKIs and attenuates downstream phospho-EGFR signaling, highlighting its essential role in sustaining oncogenic signaling under targeted therapeutic pressure. This evidence concerns the gene EGFR and non-small cell lung carcinoma.